We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+9.96%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$51.2B
AUM Growth
+$4.14B
(+8.8%)
Cap. Flow
+$445M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
19.89%
Holding
3,234
New
648
Increased
710
Reduced
838
Closed
835
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.99B |
| 2 |
Microsoft
MSFT
|
+$522M |
| 3 |
Advanced Micro Devices
AMD
|
+$511M |
| 4 |
Amazon
AMZN
|
+$318M |
| 5 |
Apple
AAPL
|
+$317M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$402M |
| 2 |
McDonald's
MCD
|
+$375M |
| 3 |
Visa
V
|
+$366M |
| 4 |
Meta Platforms (Facebook)
META
|
+$319M |
| 5 |
Adobe
ADBE
|
+$272M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.58% |
| 2 | Healthcare | 17.11% |
| 3 | Consumer Discretionary | 13.31% |
| 4 | Financials | 8% |
| 5 | Industrials | 6.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRA
1951
DELISTED
ProAssurance
PRA
| $504K | ﹤0.01% |
+33,378
| New | +$525K |
|
1952
AGCO
AGCO
$7.08B
| $502K | ﹤0.01% |
+3,820
| New | +$474K |
|
|
ZYXI
1953
DELISTED
Zynex
ZYXI
| $502K | ﹤0.01% |
52,328
-100,218
| -66% | -$1.04M |
|
1954
ProQR Therapeutics
PRQR
$272M
| $501K | ﹤0.01% |
309,459
-317,467
| -51% | -$620K |
|
1955
ARS Pharmaceuticals
SPRY
$583M
| $500K | ﹤0.01% |
74,621
+35,193
| +89% | +$235K |
|
1956
ORIX
IX
$43.1B
| $500K | ﹤0.01% |
+27,405
| New | +$475K |
|
1957
Gaotu Techedu
GOTU
$429M
| $499K | ﹤0.01% |
172,824
+145,224
| +526% | +$458K |
|
1958
Medallion Financial
MFIN
$252M
| $498K | ﹤0.01% |
62,961
+18,234
| +41% | +$125K |
|
1959
CALL
TriSalus Life Sciences Warrant
TLSIW
$38.7M
| $497K | ﹤0.01% |
47,455
| – | – |
|
1960
Stagwell
STGW
$2.27B
| $495K | ﹤0.01% |
68,670
-257,032
| -79% | -$1.7M |
|
1961
Tenaya Therapeutics
TNYA
$169M
| $494K | ﹤0.01% |
+84,181
| New | +$489K |
|
|
SEPAW
1962
CALL
DELISTED
SEP Acquisition Corp Warrants
SEPAW
| $493K | ﹤0.01% |
44,996
-5,004
| -10% | -$271 |
|
1963
Dime Commercial Bancshares
DCOM
$1.79B
| $492K | ﹤0.01% |
+27,930
| New | +$520K |
|
1964
HUTCHMED
HCM
$2.17B
| $492K | ﹤0.01% |
40,970
+16,907
| +70% | +$231K |
|
1965
Similarweb
SMWB
$633M
| $488K | ﹤0.01% |
74,426
+4,586
| +7% | +$27.8K |
|
1966
Enerpac Tool Group
EPAC
$1.91B
| $487K | ﹤0.01% |
+18,050
| New | +$458K |
|
|
SCWX
1967
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $484K | ﹤0.01% |
66,984
+42,491
| +173% | +$352K |
|
1968
Fox Factory Holding Corp
FOXF
$910M
| $483K | ﹤0.01% |
+4,453
| New | +$456K |
|
|
SY
1969
So-Young International
SY
$224M
| $483K | ﹤0.01% |
262,554
+59,786
| +29% | +$143K |
|
|
DADA
1970
DELISTED
Dada Nexus
DADA
| $481K | ﹤0.01% |
90,600
-151,739
| -63% | -$919K |
|
1971
Rush Street Interactive
RSI
$2.91B
| $481K | ﹤0.01% |
154,069
+36,939
| +32% | +$114K |
|
1972
Sportsman's Warehouse
SPWH
$46.8M
| $480K | ﹤0.01% |
84,256
-27,600
| -25% | -$166K |
|
1973
Global X MLP & Energy Infrastructure ETF
MLPX
$3.54B
| $479K | ﹤0.01% |
+11,530
| New | +$462K |
|
1974
Invesco CurrencyShares Japanese Yen Trust
FXY
$426M
| $478K | ﹤0.01% |
7,409
-1,595
| -18% | -$108K |
|
|
TWCBW
1975
CALL
DELISTED
Bilander Acquisition Corp. Warrant
TWCBW
| $477K | ﹤0.01% |
47,010
| – | – |
|
Similar funds
Marshall Wace's Q2 2023 Portfolio in Review
As of Q2 2023, Marshall Wace held 3,234 positions worth $51.2B, up 8.8% from $47.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Marshall Wace's Q2 2023 filing shows 648 new, 710 increased, 838 reduced and 835 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B. The largest sale was Gilead Sciences, an estimated $402M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Marshall Wace's largest Q2 2023 buy was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B.
- Marshall Wace added most to Microsoft in Q2 2023, an estimated $522M increase.
- Marshall Wace's biggest Q2 2023 reduction was Gilead Sciences, cutting an estimated $402M.
- Marshall Wace fully exited Cloudflare in Q2 2023, selling an estimated $136M.
- Marshall Wace's ten largest holdings make up 20% of its $51.2B portfolio in Q2 2023.
- Marshall Wace opened 648 new positions and closed 835 in Q2 2023.
- Marshall Wace's portfolio value rose 8.8% quarter-over-quarter to $51.2B.
Based on Marshall Wace's 13F filing for Q2 2023, filed 14 Aug 2023.